Glimepiride 4mg tablets

देश: यूनाइटेड किंगडम

भाषा: अंग्रेज़ी

स्रोत: MHRA (Medicines & Healthcare Products Regulatory Agency)

सक्रिय संघटक:

Glimepiride

थमां उपलब्ध:

Teva UK Ltd

ए.टी.सी कोड:

A10BB12

INN (इंटरनेशनल नाम):

Glimepiride

डोज़:

4mg

फार्मास्यूटिकल फॉर्म:

Oral tablet

प्रशासन का मार्ग:

Oral

वर्ग:

No Controlled Drug Status

प्रिस्क्रिप्शन प्रकार:

Valid as a prescribable product

उत्पाद समीक्षा:

BNF: 06010201; GTIN: 5017007031918

सूचना पत्रक

GLIMEPIRIDE 1 MG TABLETS
GLIMEPIRIDE 2 MG TABLETS
GLIMEPIRIDE 3 MG TABLETS
GLIMEPIRIDE 4 MG TABLETS
glimepiride
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START
TAKING THIS MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your
doctor or pharmacist.
• This medicine has been prescribed for you
only. Do not pass it on to others. It may harm
them, even if their signs of illness are the same
as yours.
• If you get any side effects, talk to your doctor,
or pharmacist. This includes any possible side
effects not listed in this leaflet. See section 4.
1. What Glimepiride is and what it is used for
2. What you need to know before you take
Glimepiride
3. How to take Glimepiride
4. Possible side effects
5. How to store Glimepiride
6. Contents of the pack and other information
WHAT GLIMEPIRIDE IS AND WHAT IT IS
USED FOR
Glimepiride is an orally active blood sugar
lowering medicine. This medicine belongs to a
blood sugar lowering group of medicines called
sulfonylurea. Glimepiride works by increasing
the amount of insulin released from your
pancreas. The insulin then lowers your blood
sugar levels.
WHAT GLIMEPIRIDE IS USED FOR
• Glimepiride is used to treat a certain form of
diabetes (type 2 diabetes mellitus) when diet,
physical exercise and weight reduction alone
have not been able to control your blood sugar
levels.
WHAT YOU NEED TO KNOW BEFORE YOU
TAKE GLIMEPIRIDE
DO NOT TAKE GLIMEPIRIDE IF
• You are allergic to glimepiride or other
sulfonylureas (medicines used to lower your
blood sugar such as glibenclamide) or
sulfonamides (medicines for bacterial
infections such as sulfamethoxazole) or any of
the other ingredients of this medicine (listed in
section 6)
• You have diabetes mellitus type 1
• You have diabetic ketoacidosis (a complication
of diabetes when your acid level is raised in
your body and you may have some of the
following signs: fatigue, feeling sick (nausea),
frequent urination and muscula

उत्पाद विशेषताएं

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Glimepiride 4 mg tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 4 mg glimepiride.
Excipient with known effect
Each tablet contains 138.8 mg lactose monohydrate.
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Tablet
Mottled light blue, round tablet, bisected on both sides. One side of
the tablet
debossed with “9” on one side of score and “3” on the other.
The other side of the
tablet debossed with “72” on one side of the score and “56” on
the other.
_ _
The tablet can be divided into equal doses.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Glimepiride is indicated for the treatment of type 2 diabetes
mellitus, when diet,
physical exercise and weight reduction alone are not adequate.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
The basis for successful treatment of diabetes is a good diet, regular
physical activity,
as well as routine checks of blood and urine. Tablets or insulin
cannot compensate if
the patient does not keep to the recommended diet.
Posology
Dose is determined by the results of blood and urinary glucose
determinations.
The starting dose is 1 mg glimepiride per day. If good control is
achieved this dose
should be used for maintenance therapy.
For the different dose regimens appropriate strengths are available.
If control is unsatisfactory the dose should be increased, based on
the glycaemic
control, in a stepwise manner with an interval of about 1 to 2 weeks
between each
step, to 2, 3 or 4 mg glimepiride per day.
A dose of more than 4 mg glimepiride per day gives better results only
in exceptional
cases. The maximum recommended dose is 6 mg glimepiride per day.
In patients not adequately controlled with the maximum daily dose of
metformin,
concomitant glimepiride therapy can be initiated.
While maintaining the metformin dose, the glimepiride therapy is
started with a low
dose, and is then titrated up depending on the desired level of
metabolic control up to
the ma